Clinical and Economic Burden of Managing Patients with Sickle Cell Disease Receiving Frequent Red Blood Cell Transfusions in the United States
Chuka Udeze,1 Michelle Jerry,2 Kristin A Evans,2 Nanxin Li,1 Siddharth Jain,1 Biree Andemariam3 1Health Economics and Outcomes Research, Vertex Pharmaceuticals Incorporated, Boston, MA, USA; 2Research and Analytic Services, Merative, Ann Arbor, MI, USA; 3Medicine, University of Connecticut Health, F...
Saved in:
| Main Authors: | Udeze C, Jerry M, Evans KA, Li N, Jain S, Andemariam B |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | ClinicoEconomics and Outcomes Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/clinical-and-economic-burden-of-managing-patients-with-sickle-cell-dis-peer-reviewed-fulltext-article-CEOR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sickle cell disease and Bartonella spp. infection
by: Paulo Eduardo Neves Ferreira Velho, et al.
Published: (2012-06-01) -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
by: SAGIR GUMEL AHMED
Published: (2011-01-01) -
Real-World Experience of L-Glutamine in Sickle Cell Disease: A Retrospective Observational Study
by: Shouq Turkistani, et al.
Published: (2025-06-01) -
Ten-year trends in opioid prescribing and vaso-occlusive crises in sickle cell disease: a population-based national cohort study (2011–2022)Research in context
by: Kevin Y. Xu, et al.
Published: (2025-10-01) -
Clinical Outcomes Among Patients With Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review
by: Nair R, et al.
Published: (2025-03-01)